Add like
Add dislike
Add to saved papers

Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.

OBJECTIVE: The purpose of this article is to evaluate the utility of diffusion-weighted imaging (DWI) and blood oxygenation level-dependent (BOLD) MRI for characterizing renal cell carcinoma (RCC) subtypes at 3 T.

MATERIALS AND METHODS: Seventy-seven patients underwent 3-T DWI and BOLD MRI. Apparent diffusion coefficient (ADC; × 10(-3) mm(2)/s) and rate of spin dephasing (R2*, which equals 1 / T2* relaxation time, or 1/s) values were measured in the three RCC subtypes and normal renal parenchyma, and the results were compared. Statistical analyses were performed using analysis of variance, Student t test, and ROC curve analysis.

RESULTS: Clear cell RCCs showed statistically significantly greater ADC values (1.81 × 10(-3) mm(2)/s) than did papillary (1.29 × 10(-3) mm(2)/s) and chromophobe (1.55 × 10(-3) mm(2)/s) RCCs (p < 0.01); however, no statistically significant differences between papillary and chromophobe RCCs were observed (p = 0.26). Chromophobe RCCs showed the greatest mean R2* (33.6 1/s) of the three subtypes (p < 0.01); however, no statistically significant differences between clear cell RCCs and papillary RCCs were seen (p = 0.48). Low-grade clear cell RCCs showed statistically significantly higher ADC value (1.97 × 10(-3) mm(2)/s) than did high-grade clear cell RCCs (1.66 × 10(-3) mm(2)/s; p = 0.021). For differentiating clear cell RCCs from non-clear cell RCCs, the AUCs of ADC and R2* values were 0.756 × 10(-3) mm(2)/s and 0.607 (1/s), respectively (p = 0.047): cutoff values of ADC (1.4 × 10(-3) mm(2)/s) and R2* (26.3 1/s) resulted in sensitivities and specificities of 85% and 73%, and 86% and 47%, respectively.

CONCLUSION: For characterizing RCC subtypes, DWI and BOLD MRI at 3 T may be useful, but the current technique of BOLD MRI seems to have a limited diagnostic accuracy.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app